AML pathways include the nuclear factor kappa-B [34], mitogen-activated protein kinase (MAPK) [35], Wnt/β-catenin [36,37,38], PI3K/Akt/mTOR [39], Ras/raf/MEK/ERK [40] and aryl hydrocarbon receptor (AhR) signaling pathways [41]. This evidence concerns the gene AHR and acute myeloid leukemia.